Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label updated from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T15:44:48.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, has been added to the study record history. The previous entry, v3.6.6, has been removed, updating the record's version history.
    Difference
    0.1%
    Check dated 2026-09-19T18:02:00.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The Record History page lists a new Revision: v3.6.6, replacing v3.6.5, indicating a software/UI update to the history display.
    Difference
    0.1%
    Check dated 2026-08-29T20:58:14.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry labeled v3.6.5, and the previous v3.6.4 entry has been removed from the list.
    Difference
    0.1%
    Check dated 2026-08-08T16:12:56.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 entry was added to the record history, replacing the previous v3.6.3, signaling a small site update.
    Difference
    0.1%
    Check dated 2026-07-25T08:27:27.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The record history adds a new revision entry (v3.6.3) and removes the previous revision (v3.6.2), indicating a metadata/version update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T20:25:53.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.